Skip to main content
. 2023 Apr 29;16:42. doi: 10.1186/s13045-023-01437-1

Fig. 5.

Fig. 5

Cumulative incidence of overall survival (A), event-free survival (B), relapse(C) and disease-free survival (D) among patients who received or did not receive allo-HSCT. HSCT, hematopoietic stem cell transplantation